Ardent Health Partners, Inc. (ARDT) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Ardent Health Partners, Inc. stock (ARDT) is currently trading at $8.78. Ardent Health Partners, Inc. PE ratio is 8.82. Ardent Health Partners, Inc. PS ratio (Price-to-Sales) is 0.19. Analyst consensus price target for ARDT is $12.73. WallStSmart rates ARDT as Underperform.
- ARDT PE ratio analysis and historical PE chart
- ARDT PS ratio (Price-to-Sales) history and trend
- ARDT intrinsic value — DCF, Graham Number, EPV models
- ARDT stock price prediction 2025 2026 2027 2028 2029 2030
- ARDT fair value vs current price
- ARDT insider transactions and insider buying
- Is ARDT undervalued or overvalued?
- Ardent Health Partners, Inc. financial analysis — revenue, earnings, cash flow
- ARDT Piotroski F-Score and Altman Z-Score
- ARDT analyst price target and Smart Rating
Ardent Health Partners, Inc.
📊 No data available
Try selecting a different time range
ARDT Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Ardent Health Partners, Inc. (ARDT)
ARDT trades 43% above its Graham fair value of $6.53, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Ardent Health Partners, Inc. (ARDT) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book, institutional own.. Concerns around operating margin and revenue growth. Mixed signals suggest waiting for clearer direction before acting.
Ardent Health Partners, Inc. (ARDT) Key Strengths (3)
Paying less than $1 for every $1 of annual revenue
Trading below book value, meaning the market prices it less than net assets
74.89% of shares held by major funds and institutions
Supporting Valuation Data
Ardent Health Partners, Inc. (ARDT) Areas to Watch (6)
Revenue declining -0.10%, a shrinking business
Earnings declining -60.60%, profits shrinking
Very thin margins with limited operational efficiency
Very thin margins, barely profitable
Small-cap company with higher risk but more growth potential
Moderate profitability with room for improvement
Ardent Health Partners, Inc. (ARDT) Detailed Analysis Report
Overall Assessment
This company scores 45/100 in our Smart Analysis, earning a D+ grade. Out of 9 metrics analyzed, 3 register as strengths (avg 10.0/10) while 6 fall into concern territory (avg 2.3/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book, Institutional Own.. Valuation metrics including Price/Sales (0.19), Price/Book (0.94) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Revenue Growth, EPS Growth, Operating Margin. Growth concerns include Revenue Growth at -0.10%, EPS Growth at -60.60%, which may limit upside. Profitability pressure is visible in Return on Equity at 14.30%, Operating Margin at 6.53%, Profit Margin at 2.15%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Revenue Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 14.30% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -0.10% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Revenue Growth and EPS Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
ARDT Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
ARDT's Price-to-Sales ratio of 0.19x trades 38% below its historical average of 0.31x (0th percentile). The current valuation is 63% below its historical high of 0.52x set in Aug 2024, and 1% above its historical low of 0.19x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~0.3x as trailing revenue scaled faster than the stock price.
Compare ARDT with Competitors
Top MEDICAL CARE FACILITIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Ardent Health Partners, Inc. (ARDT) · HEALTHCARE › MEDICAL CARE FACILITIES
The Big Picture
Ardent Health Partners, Inc. faces headwinds with declining revenue, though profitability provides a cushion. Revenue reached 6.3B with 10% decline year-over-year. Profit margins are strong at 215.0%, reflecting pricing power and operational efficiency.
Key Findings
ROE of 1430.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Generating 138M in free cash flow and 222M in operating cash flow. Earnings are translating into actual cash generation.
Revenue contracted 10% YoY. Worth determining whether this is cyclical or structural.
What to Watch Next
Debt management: total debt of 2.3B is significantly higher than cash (609M). Monitor refinancing risk.
Sector dynamics: monitor MEDICAL CARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact Ardent Health Partners, Inc..
Bottom Line
Ardent Health Partners, Inc. faces challenges with declining revenue. While profitability provides a buffer, the long-term trajectory needs to improve. Watch for management's strategic response and whether the company can stabilize or pivot to new growth drivers.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 8:28:28 AM
About Ardent Health Partners, Inc.(ARDT)
NYSE
HEALTHCARE
MEDICAL CARE FACILITIES
USA
Ardent Health Partners, Inc., based in Nashville, Tennessee, is a leading healthcare organization dedicated to providing high-quality, patient-centered care through its extensive network of hospitals and outpatient facilities. The company's strong portfolio of acute care hospitals is complemented by its commitment to innovation in healthcare solutions, allowing it to effectively address the evolving needs of diverse communities. With a robust financial framework, Ardent is strategically poised for growth, aiming to improve healthcare access and outcomes while skillfully navigating the complexities of the contemporary healthcare environment.